1cP-AL-LAD: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A psychedelic compound | {{Short description|A synthetic psychedelic compound}} | ||
{{ | {{Drugbox | ||
| verifiedfields = changed | |||
| verifiedrevid = 477002547 | |||
| image = 1CP-AL-LAD_structure.png | |||
| image_size = 200px | |||
| image_alt = Chemical structure of 1cP-AL-LAD | |||
| image_caption = Chemical structure of 1cP-AL-LAD | |||
}} | |||
'''1cP-AL-LAD''' is a | '''1cP-AL-LAD''' is a synthetic psychedelic compound that belongs to the [[lysergamide]] class. It is structurally related to [[LSD]] and is known for its psychoactive effects. 1cP-AL-LAD is a derivative of [[AL-LAD]], with a cyclopropylcarbonyl group attached to the nitrogen of the indole ring. | ||
==Chemical | ==Chemical Structure== | ||
[[File:1CP-AL-LAD_structure.png|thumb|right|Chemical structure of 1cP-AL-LAD]] | |||
1cP-AL-LAD is a lysergamide, which means it is a derivative of [[lysergic acid]]. The chemical structure of 1cP-AL-LAD includes a cyclopropylcarbonyl group, which is a distinguishing feature from other lysergamides such as [[LSD]] and [[AL-LAD]]. This modification is believed to affect the compound's pharmacokinetics and pharmacodynamics. | |||
The chemical structure of 1cP-AL-LAD is | |||
[[ | |||
==Pharmacology== | ==Pharmacology== | ||
1cP-AL-LAD | 1cP-AL-LAD acts primarily as a partial agonist at the [[serotonin receptor|5-HT2A receptor]], which is thought to be responsible for its psychedelic effects. Like other psychedelics, it may also interact with other serotonin receptors, contributing to its overall psychoactive profile. The exact mechanism of action and the full spectrum of its effects are still under investigation. | ||
==Effects== | ==Effects== | ||
The effects of 1cP-AL-LAD are similar to those of other | The effects of 1cP-AL-LAD are similar to those of other psychedelics, such as [[LSD]] and [[psilocybin]]. Users report altered perceptions, visual hallucinations, and changes in thought processes. The onset of effects typically occurs within 30 to 90 minutes after ingestion, with the experience lasting between 6 to 10 hours. | ||
==Legal Status== | |||
The legal status of 1cP-AL-LAD varies by country. In some jurisdictions, it may be considered a controlled substance due to its structural similarity to other illegal psychedelics. In others, it may be legal or exist in a legal gray area. Users should be aware of the laws in their specific location before obtaining or using 1cP-AL-LAD. | |||
== | ==Safety and Risks== | ||
As with other psychedelics, the use of 1cP-AL-LAD carries potential risks, including psychological distress, anxiety, and the possibility of triggering latent mental health disorders. It is important for users to approach its use with caution, ideally in a safe and controlled environment. | |||
==Related pages== | ==Related pages== | ||
* [[LSD]] | * [[LSD]] | ||
* [[AL-LAD]] | * [[AL-LAD]] | ||
* [[Psychedelic drug]] | * [[Psychedelic drug]] | ||
* [[Serotonin receptor]] | |||
[[Category:Psychedelic drugs]] | [[Category:Psychedelic drugs]] | ||
[[Category:Lysergamides]] | [[Category:Lysergamides]] | ||
Latest revision as of 11:18, 15 February 2025
A synthetic psychedelic compound
| 1cP-AL-LAD | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
1cP-AL-LAD is a synthetic psychedelic compound that belongs to the lysergamide class. It is structurally related to LSD and is known for its psychoactive effects. 1cP-AL-LAD is a derivative of AL-LAD, with a cyclopropylcarbonyl group attached to the nitrogen of the indole ring.
Chemical Structure[edit]
1cP-AL-LAD is a lysergamide, which means it is a derivative of lysergic acid. The chemical structure of 1cP-AL-LAD includes a cyclopropylcarbonyl group, which is a distinguishing feature from other lysergamides such as LSD and AL-LAD. This modification is believed to affect the compound's pharmacokinetics and pharmacodynamics.
Pharmacology[edit]
1cP-AL-LAD acts primarily as a partial agonist at the 5-HT2A receptor, which is thought to be responsible for its psychedelic effects. Like other psychedelics, it may also interact with other serotonin receptors, contributing to its overall psychoactive profile. The exact mechanism of action and the full spectrum of its effects are still under investigation.
Effects[edit]
The effects of 1cP-AL-LAD are similar to those of other psychedelics, such as LSD and psilocybin. Users report altered perceptions, visual hallucinations, and changes in thought processes. The onset of effects typically occurs within 30 to 90 minutes after ingestion, with the experience lasting between 6 to 10 hours.
Legal Status[edit]
The legal status of 1cP-AL-LAD varies by country. In some jurisdictions, it may be considered a controlled substance due to its structural similarity to other illegal psychedelics. In others, it may be legal or exist in a legal gray area. Users should be aware of the laws in their specific location before obtaining or using 1cP-AL-LAD.
Safety and Risks[edit]
As with other psychedelics, the use of 1cP-AL-LAD carries potential risks, including psychological distress, anxiety, and the possibility of triggering latent mental health disorders. It is important for users to approach its use with caution, ideally in a safe and controlled environment.
